A low-dose combination of ketamine and guanosine counteracts corticosterone-induced depressive-like behavior and hippocampal synaptic impairments via mTORC1 signaling

Publication date: Available online 2 June 2021Source: Progress in Neuro-Psychopharmacology and Biological PsychiatryAuthor(s): Anderson Camargo, Ana Paula Dalmagro, Ingrid A.V. Wolin, Aline Siteneski, Ana Lúcia B. Zeni, Ana Lúcia S. Rodrigues
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - Category: Psychiatry Source Type: research